{"id":727,"date":"2016-01-12T15:56:57","date_gmt":"2016-01-12T10:26:57","guid":{"rendered":"https:\/\/delveinsightblog.wordpress.com\/?p=727"},"modified":"2025-05-05T17:10:36","modified_gmt":"2025-05-05T11:40:36","slug":"pancreatic-cancer-pipeline-insights-2016","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016","title":{"rendered":"\u00a0 Pancreatic Cancer-Pipeline Insights, 2016"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-69fc214e1813b\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-69fc214e1813b\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#DelveInsight_the_leading_market_research_and_consulting_company_has_added_new_report_Pancreatic_Cancer-Pipeline_Insights_2016_to_its_portfolio_With_this_launch_Delveinsight_now_has_700_Reports_on_Indication_Pipeline_Insight_In_addition_to_this_our_research_expertise_provides_our_clients_with_up_to_date_information_of_market_till_date_order_has_been_placed\" >DelveInsight, the leading market research and consulting company has added new report &nbsp; Pancreatic Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#The_Indication_pipeline_Insight_Reports_provides_client_with_details_Pancreatic_Cancer_Pipeline_products_across_the_globe_It_comprehensively_includes\" >The Indication pipeline Insight Reports provides client with details Pancreatic Cancer Pipeline products across the globe. It comprehensively includes:<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#Comparative_study_of_drugs_under_development\" >Comparative study of drugs under development.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#Information_on_several_other_drugs_as_well_among_which_12_are_in_phase_III_39_in_phase_II_39_in_phase_I_13_in_pre_%E2%80%93_clinical_and_41_in_dormant_phase\" >Information on several other drugs as well among which 12 are in phase III, 39 in phase II, 39 in phase I, 13 in pre &#8211; clinical and 41 in dormant phase.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#R_D_activities_and_technologies_used_along_with_the_pipeline_molecules_in_development\" >R&amp;D activities and technologies used along with the pipeline molecules in development.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#Information_related_to_collaborations_in-licensing_and_out-licensing_deals\" >Information related to collaborations, in-licensing and out-licensing deals.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#Stages_of_development_of_pipeline_molecules\" >Stages of development of pipeline molecules.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#Therapeutic_assessments_by_molecule_types_route_of_administration_monotherapy_and_combination_products\" >Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#Pancreatic_Cancer_-Pipeline_Insights_2016_Report_envisages_Pipeline_Intelligence_by_identifying_the_key_players_along_with_their_potential_pipeline_molecule_Therefore_DelveInsights_report_on_Pancreatic_Cancer_helps_to_optimize_portfolio_by_creating_effective_counter-strategies_to_gain_competitive_and_therapeutic_advantage_in_global_Pharma_market_In_addition_it_assesses_the_major_market_drivers_and_barriers_in_development_of_Pipeline_molecules_which_helps_to_understand_market_for_collaborations_and_licensing_deals\" >Pancreatic Cancer -Pipeline Insights, 2016 Report envisages Pipeline Intelligence by identifying the key players along with their potential pipeline molecule. Therefore DelveInsight\u2019s report on Pancreatic Cancer helps to optimize portfolio by creating effective counter-strategies to gain competitive and therapeutic advantage in global Pharma market. In addition, it assesses the major market drivers and barriers in development of Pipeline molecules which helps to understand market for collaborations and licensing deals.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#DelveInsight_is_offering_the_Report_at_a_price_of_USD_2250_as_a_single_user_license_USD_4500_as_a_site_license_and_USD_6700_as_a_GlobalEnterprise_License\" >DelveInsight is offering the Report at a price of USD 2,250 as a single user license, USD 4,500 as a site license and USD 6,700 as a Global\/Enterprise License.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#For_more_information_on_Pipeline_Insight_Reports_email_at_infodelveInsightcom\" >For more information on Pipeline Insight Reports, email at info@delveInsight.com<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#Contact_Us\" >Contact Us:<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#DelveInsight_Business_Research\" >DelveInsight Business Research<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#New_Delhi-110075_India\" >New Delhi-110075, India<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#Phone_91-11-45689769_91_9650213330\" >Phone: +91-11-45689769, +91 9650213330<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#Website_https_wwwdelveinsightcom\" >Website: https:\/\/www.delveinsight.com<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#About_Us\" >About Us<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\/#DelveInsight_is_a_leading_Business_Consulting_and_Market_Research_Firm_We_help_our_clients_to_find_answers_relevant_to_their_business_facilitating_decision-making_identify_potential_market_opportunities_competitor_assessments_and_business_environmental_assessment_In_addition_to_this_DelveInsight_also_deals_in_providing_custom_research_services_in_coherence_with_interest_area_of_the_clients\" >DelveInsight is a leading Business Consulting and Market Research Firm.&nbsp; We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.<\/a><\/li><\/ul><\/nav><\/div>\n<h6><span class=\"ez-toc-section\" id=\"DelveInsight_the_leading_market_research_and_consulting_company_has_added_new_report_Pancreatic_Cancer-Pipeline_Insights_2016_to_its_portfolio_With_this_launch_Delveinsight_now_has_700_Reports_on_Indication_Pipeline_Insight_In_addition_to_this_our_research_expertise_provides_our_clients_with_up_to_date_information_of_market_till_date_order_has_been_placed\"><\/span>DelveInsight, the leading market research and consulting company has added new report &nbsp; Pancreatic Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed.<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h6><span class=\"ez-toc-section\" id=\"The_Indication_pipeline_Insight_Reports_provides_client_with_details_Pancreatic_Cancer_Pipeline_products_across_the_globe_It_comprehensively_includes\"><\/span>The Indication pipeline Insight Reports provides client with details Pancreatic Cancer Pipeline products across the globe. It comprehensively includes:<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h6><\/h6>\n<ul>\n<li>\n<h6><span class=\"ez-toc-section\" id=\"Comparative_study_of_drugs_under_development\"><\/span>Comparative study of drugs under development.<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<\/li>\n<li>\n<h6><span class=\"ez-toc-section\" id=\"Information_on_several_other_drugs_as_well_among_which_12_are_in_phase_III_39_in_phase_II_39_in_phase_I_13_in_pre_%E2%80%93_clinical_and_41_in_dormant_phase\"><\/span>Information on several other drugs as well among which<strong> 12 are in phase III, 39 in phase II, 39 in phase I, 13 in pre &#8211; clinical and 41 in dormant phase.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h6>\n<\/li>\n<li>\n<h6><span class=\"ez-toc-section\" id=\"R_D_activities_and_technologies_used_along_with_the_pipeline_molecules_in_development\"><\/span>R&amp;D activities and technologies used along with the pipeline molecules in development.<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<\/li>\n<li>\n<h6><span class=\"ez-toc-section\" id=\"Information_related_to_collaborations_in-licensing_and_out-licensing_deals\"><\/span>Information related to collaborations, in-licensing and out-licensing deals.<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<\/li>\n<li>\n<h6><span class=\"ez-toc-section\" id=\"Stages_of_development_of_pipeline_molecules\"><\/span>Stages of development of pipeline molecules.<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<\/li>\n<li>\n<h6><span class=\"ez-toc-section\" id=\"Therapeutic_assessments_by_molecule_types_route_of_administration_monotherapy_and_combination_products\"><\/span>Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<\/li>\n<\/ul>\n<h6><\/h6>\n<h6><span class=\"ez-toc-section\" id=\"Pancreatic_Cancer_-Pipeline_Insights_2016_Report_envisages_Pipeline_Intelligence_by_identifying_the_key_players_along_with_their_potential_pipeline_molecule_Therefore_DelveInsights_report_on_Pancreatic_Cancer_helps_to_optimize_portfolio_by_creating_effective_counter-strategies_to_gain_competitive_and_therapeutic_advantage_in_global_Pharma_market_In_addition_it_assesses_the_major_market_drivers_and_barriers_in_development_of_Pipeline_molecules_which_helps_to_understand_market_for_collaborations_and_licensing_deals\"><\/span>Pancreatic Cancer -Pipeline Insights, 2016 Report envisages Pipeline Intelligence by identifying the key players along with their potential pipeline molecule. Therefore DelveInsight\u2019s report on Pancreatic Cancer helps to optimize portfolio by creating effective counter-strategies to gain competitive and therapeutic advantage in global Pharma market. In addition, it assesses the major market drivers and barriers in development of Pipeline molecules which helps to understand market for collaborations and licensing deals.<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h6><\/h6>\n<h6><span class=\"ez-toc-section\" id=\"DelveInsight_is_offering_the_Report_at_a_price_of_USD_2250_as_a_single_user_license_USD_4500_as_a_site_license_and_USD_6700_as_a_GlobalEnterprise_License\"><\/span>DelveInsight is offering the Report at a price of USD 2,250 as a single user license, USD 4,500 as a site license and USD 6,700 as a Global\/Enterprise License.<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h6><span class=\"ez-toc-section\" id=\"For_more_information_on_Pipeline_Insight_Reports_email_at_infodelveInsightcom\"><\/span>For more information on Pipeline Insight Reports, email at <a href=\"mailto:info@delveInsight.com\">info@delveInsight.com<\/a><span class=\"ez-toc-section-end\"><\/span><\/h6>\n<p>&nbsp;<\/p>\n<h6><span class=\"ez-toc-section\" id=\"Contact_Us\"><\/span>Contact Us:<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h6><span class=\"ez-toc-section\" id=\"DelveInsight_Business_Research\"><\/span>DelveInsight Business Research<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h6><span class=\"ez-toc-section\" id=\"New_Delhi-110075_India\"><\/span>New Delhi-110075, India<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h6><span class=\"ez-toc-section\" id=\"Phone_91-11-45689769_91_9650213330\"><\/span>Phone: +91-11-45689769, +91 9650213330<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h6><span class=\"ez-toc-section\" id=\"Website_https_wwwdelveinsightcom\"><\/span>Website: https:\/\/www.delveinsight.com<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h6><\/h6>\n<h6><span class=\"ez-toc-section\" id=\"About_Us\"><\/span>About Us<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h6><span class=\"ez-toc-section\" id=\"DelveInsight_is_a_leading_Business_Consulting_and_Market_Research_Firm_We_help_our_clients_to_find_answers_relevant_to_their_business_facilitating_decision-making_identify_potential_market_opportunities_competitor_assessments_and_business_environmental_assessment_In_addition_to_this_DelveInsight_also_deals_in_providing_custom_research_services_in_coherence_with_interest_area_of_the_clients\"><\/span>DelveInsight is a leading Business Consulting and Market Research Firm.&nbsp; We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight, the leading market research and consulting company has added new report &nbsp; Pancreatic Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[173,204],"industry":[17225],"therapeutic_areas":[17228,17234],"class_list":["post-727","post","type-post","status-publish","format-standard","hentry","category-articles","tag-collaborations","tag-delveinsight","industry-pharmaceutical","therapeutic_areas-oncology","therapeutic_areas-rare-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u00a0 Pancreatic Cancer-Pipeline Insights, 2016 - DelveInsight Business Research<\/title>\n<meta name=\"description\" content=\"The Indication Pipeline Insight Reports Provides Client With Details Pancreatic Cancer Pipeline Products Across The Globe.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00a0 Pancreatic Cancer-Pipeline Insights, 2016 - DelveInsight Business Research\" \/>\n<meta property=\"og:description\" content=\"The Indication Pipeline Insight Reports Provides Client With Details Pancreatic Cancer Pipeline Products Across The Globe.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-01-12T10:26:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-05T11:40:36+00:00\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u00a0 Pancreatic Cancer-Pipeline Insights, 2016 - DelveInsight Business Research","description":"The Indication Pipeline Insight Reports Provides Client With Details Pancreatic Cancer Pipeline Products Across The Globe.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016","og_locale":"en_US","og_type":"article","og_title":"\u00a0 Pancreatic Cancer-Pipeline Insights, 2016 - DelveInsight Business Research","og_description":"The Indication Pipeline Insight Reports Provides Client With Details Pancreatic Cancer Pipeline Products Across The Globe.","og_url":"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2016-01-12T10:26:57+00:00","article_modified_time":"2025-05-05T11:40:36+00:00","author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016","url":"https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016","name":"\u00a0 Pancreatic Cancer-Pipeline Insights, 2016 - DelveInsight Business Research","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"datePublished":"2016-01-12T10:26:57+00:00","dateModified":"2025-05-05T11:40:36+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"The Indication Pipeline Insight Reports Provides Client With Details Pancreatic Cancer Pipeline Products Across The Globe.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/pancreatic-cancer-pipeline-insights-2016"]}]},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":null,"coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">collaborations<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">DelveInsight<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">collaborations<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 10 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Jan 12, 2016","modified":"Updated on May 5, 2025"},"absolute_dates_time":{"created":"Posted on Jan 12, 2016 3:56 pm","modified":"Updated on May 5, 2025 5:10 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=727"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/727\/revisions"}],"predecessor-version":[{"id":31663,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/727\/revisions\/31663"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=727"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=727"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}